Weight Loss Clinical Trials in Fort Worth, TX

11 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus	Phase 2	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	30 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	31 mi
Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino	N/A	Baylor Research Institute	31 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	31 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	Phase 2	Eli Lilly and Company	31 mi
A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities	Phase 2	Verdiva Bio Dev Limited	31 mi
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes	Phase 1	Eli Lilly and Company	31 mi
The Effect of Adiposity on Muscle and Microvascular Function in HFpEF	—	University of Texas Southwestern Medical Center	31 mi
Tailored Exercise Training Study Among Adults With HFpEF	Phase 2/3	University of Texas Southwestern Medical Center	31 mi
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)	N/A	Baylor Research Institute	31 mi
Tirzepatide Weight Loss for MRD+ Early Breast Cancer	Phase 2	Baylor Research Institute	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.